Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Microencapsul ; 17(5): 639-50, 2000.
Article in English | MEDLINE | ID: mdl-11038122

ABSTRACT

The purpose of this study was to investigate possible immunomodulatory and cytotoxic effects of solid lipid nanoparticles (SLN) on murine peritoneal macrophages. Immunomodulatory effects of SLN composed of either a lipid- (glycerol-behenate) or a wax (cetylpalmitate) matrix stabilized by the surfactant Poloxamer 188 were analysed by detection of proinflammatory and down-regulatory cytokines in supernatants of thioglycollate-elicited peritoneal macrophages using enzyme-linked immunosorbent assay (ELISA). Cytotoxicity of SLN was assessed using the ITT test. Incubation of macrophages with either SLN at low concentrations did not increase production of interleukin (IL)-6, IL-12, and tumour necrosis factor (TNF)-alpha. At higher SLN concentrations, a concentration-dependent decrease in IL-6 secretion was observed compared to background production of IL-6 by untreated macrophages. IL-12 and TNF-alpha production was neither detected in supernatants of macrophages treated with SLN at any concentration nor in those of untreated cells. The decrease in IL-6 secretion was paralleled by concentration-dependent cytotoxicity of SLN on these cells. In contrast, incubation with polystyrene reference particles neither resulted in decreased IL-6 production nor in a loss of viability. SLN-treated macrophages were found to up-regulate their cytokine production following stimulation with Pansorbin, despite the concentration-dependent cytotoxicity induced by SLN. Down-regulatory effects on SLN-treated macrophages by IL-10 were not observed. In conclusion, incubation of SLN with murine peritoneal macrophages did not induce the production of proinflammatory and down-regulatory cytokines. At high concentrations of SLN, cytotoxic effects on these cells were observed. Cytotoxicity appears to be the main cause of decreased cytokine production by these cells.


Subject(s)
Capsules/pharmacology , Cytokines/biosynthesis , Macrophages, Peritoneal/drug effects , Adjuvants, Immunologic/pharmacology , Animals , Capsules/toxicity , Cell Survival/drug effects , Female , In Vitro Techniques , Interleukin-12/biosynthesis , Interleukin-6/biosynthesis , Lipids , Macrophages, Peritoneal/cytology , Macrophages, Peritoneal/immunology , Mice , Mice, Inbred BALB C , Microspheres , Tumor Necrosis Factor-alpha/biosynthesis
2.
Int J Pharm ; 196(2): 235-9, 2000 Mar 10.
Article in English | MEDLINE | ID: mdl-10699726

ABSTRACT

In order to investigate the interaction of preserved solid lipid nanoparticles (SLN) with murine peritoneal macrophages (Mpsi), cytotoxicity and proinflammatory effects of two different solid lipid nanoparticles (SLN) preparations consisting of either compritol (CO) or cetyl palmitate (CP) preserved with thiomersal were analyzed. Concentration-dependent cytotoxic effects were observed using the 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT) assay. Secretion of interleukin-6 by Mpsi following incubation with CO and CP SLN did not differ from secretion by untreated cells; proinflammatory cytokines interleukin-12 and tumor-necrosis-factor-alpha as further indicators of immunomodulatory effects were not detectable. These findings paralleled our previous findings that unpreserved CO and CP SLN did not induce immunomodulatory effects but cytotoxicity at higher concentrations. There were no synergistic cytotoxic effects of preservative and SLN. Thus, preservation of SLN using thiomersal does not appear to cause increased cytotoxicity and immunomodulatory effects following incubation with Mpsi.


Subject(s)
Lipids/administration & dosage , Macrophages, Peritoneal/drug effects , Preservatives, Pharmaceutical/toxicity , Animals , Cell Survival/drug effects , Culture Media, Conditioned/chemistry , Dose-Response Relationship, Drug , Drug Carriers/administration & dosage , Drug Carriers/chemistry , Drug Compounding , Enzyme-Linked Immunosorbent Assay , Excipients/administration & dosage , Excipients/chemistry , Fatty Acids/administration & dosage , Fatty Acids/chemistry , Female , Interleukin-12/analysis , Interleukin-6/analysis , Lipids/chemistry , Macrophages, Peritoneal/cytology , Mice , Mice, Inbred BALB C , Palmitates/administration & dosage , Palmitates/chemistry , Particle Size , Poloxamer/administration & dosage , Poloxamer/chemistry , Preservatives, Pharmaceutical/chemistry , Thimerosal/administration & dosage , Thimerosal/chemistry , Tumor Necrosis Factor-alpha/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...